Subsense
Latest round
- Seed
Last raised
- Dec 2025
Total raised
- $25M
Investors
- 1
About Subsense
Subsense Inc.Founded in 2022 in Covina, US, Subsense Inc. specializes in non-surgical brain-computer interface technology. Founded in 2022 in Covina, US, Subsense Inc. specializes in non-surgical brain-computer interface technology. Founder details are not available, and no mention of subsidiaries or prior mergers exists.00 mn. Subsense specializes in the development of non-surgical bidirectional brain-computer interfaces (BCIs) designed to transform health and enhance human capabilities. The core product leverages biocompatible nanoparticles engineered to stimulate and record neural activity, facilitating seamless communication between human cognition and technology. The BCI technology primarily targets individuals with paralysis and neurological disorders, enabling them to control digital devices through thought alone, thereby improving independence and quality of life. Applications extend to treating neurological and neurodegenerative diseases, providing real-time diagnostics, and enhancing human-machine interaction across various platforms.Subsense's revenue model is structured around B2B partnerships and direct-to-consumer engagements, focusing on healthcare providers and technology integrators. The company offers its flagship BCI technology through customized solutions tailored to specific client needs, which may include subscription-based services for ongoing support and upgrades. Revenue streams are generated through initial product sales and recurring fees associated with software updates and maintenance. Clients include healthcare facilities and research institutions seeking advanced solutions for patient treatment and monitoring. The commercial strategy emphasizes long-term collaborations, ensuring alignment with market demands and enhanced product offerings. Plans for the future include the development of additional BCI products targeting new therapeutic applications, with a focus on launching these new offerings within the next 18 months. Subsense is also planning to expand its market presence into Europe by 2026, aiming to establish critical partnerships with healthcare providers.
Who invested in Subsense
1 investor across 2 rounds
See all investors in Subsense
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Subsense
Who invested in Subsense?
Subsense has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Subsense raised?
Subsense has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Subsense last raise money?
Subsense's most recent round on record is a Seed, in Dec 2025.
What does Subsense do?
Subsense is a biotechnology company.
Where is Subsense headquartered?
Subsense is headquartered in Covina, US.
Which VCs invest in companies like Subsense?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Subsense's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Subsense? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.